Table 1 Pancreaticoduodenectomy after esophagectomy with a gastric conduit
Author | Year | Age | Sex | Diagnosis | Interval between esophagectomy and PD (month) | Operation | Preservation | Reconstruction | Operation time (min) | Blood loss (ml) | Complication | Recurrence /RFS (month) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Maeta [15] | 1994 | 63 | M | Pancreatic head carcinoma | 72 | PD | RGEA and V | None | – | – | None | None/12 |
Watanabe [16] | 1995 | 65 | M | Pancreatic metastasis of esophageal carcinoma | 18 | PD | RGEA and V | None | – | – | None | – |
Hamaji [17] | 1999 | 67 | M | Gastric tube carcinoma | 240 | PD | None | None | – | – | Delayed oral intake | None/12 |
Kaneko [18] | 2000 | 71 | M | IPMC of the pancreatic head | 108 | PD | RGEA | None | – | – | Pancreatic fistula | None/11 |
Toyoda [19] | 2001 | 75 | F | Carcinoma of the ampulla of Vater | 132 | PPPD | RGEA | None | – | – | None | None/6 |
Kurosaki [20] | 2003 | 58 | M | Bile duct carcinoma | 60 | PPPD | RGEA and V | None | – | – | None | – |
Uehara [21] | 2004 | 57 | M | IPMN of the pancreatic head | 24 | PD | RGEA and V | None | – | – | None | – |
Tanaka [22] | 2005 | 69 | M | Carcinoma of the ampulla of Vater | 14 | PPPD | RGEA and V | None | 555 | 425 | None | None/36 |
Ikeda [23] | 2006 | 63 | M | Pancreatic head carcinoma | 120 | PD | RGEA and V | None | 600 | 1080 | None | None/12 |
Tobita [24] | 2009 | 81 | M | IPMN of the pancreatic head | 72 | DPPHR | RGEA and V | None | – | – | None | None/48 |
Hatori [25] | 2009 | 70 | M | Pancreatic head carcinoma | 96 | PD | RGEA and V | None | – | – | None | Yes/10 |
Yada [26] | 2010 | 77 | M | Duodenal carcinoma | 204 | PD | RGEA and V | None | – | – | None | None/18 |
Ando [27] | 2010 | 67 | M | Carcinoma of the ampulla of Vater | 60 | PPPD | RGEA and V | None | 277 | 445 | None | None/36 |
Addeo [28] | 2011 | 73 | M | Pancreatic metastasis of renal cell carcinoma | 72 | PPPD | RGEA and V | None | 300 | 300 | Pancreatic fistula | – |
Fragulidis [29] | 2011 | 50 | M | Pancreatic head carcinoma | 156 | PPPD | RGEA | None | 420 | 800 | None | None/6 |
Inoue [30] | 2014 | 72 | M | Pancreatic head carcinoma | 120 | PD | Reconstruction | GDA and RGEA/RGEV and LRV | 863 | 3000 | None | None/6 |
Okochi [31] | 2015 | 70 | M | Pancreatic head carcinoma | 60 | PD | Reconstruction | MCA and RGEA | – | – | – | None/8 |
Orii [32] | 2019 | 79 | M | Pancreatic head carcinoma | 60 | PPPD | RGEA and V | None | – | – | None | None/63 |
Izumi [33] | 2019 | 78 | M | Pancreatic head carcinoma | 84 | PD | RGEA and V | None | 492 | 652 | None | None/5 |
Honig [34] | 2020 | 72 | M | Pancreatic head carcinoma | 132 | PPPD | RGEA and V | None | – | – | Duodenojejunostomy leak | – |
Ours | 2020 | 76 | M | Pancreatic head carcinoma | 96 | PD | RGEV Reconstruction | MCA and RGEA | 598 | 350 | Gastrojejunostomy leak | None/15 |